医渡科技(02158.HK)今日盘中股价大涨5.82%,引发市场热议。分析人士认为,此轮上涨或与公司布局前景广阔的数字化医疗业务吸引资金流入有关。
数据显示,医渡科技为中国领先的医疗大数据解决方案提供商,拥有YiduCore大数据智能基础设施。公司业务覆盖范围广,除大数据平台及解决方案外,还提供生命科学分析服务、健康管理平台等。特别是健康管理平台针对保险公司,提供保险科技与疾病管理解决方案,在医疗数字化转型中潜力巨大。
资金面上,数据显示公司最新季度营收3.65亿港元,虽然净利润仍为负值,但三家机构皆给予"买入"评级。市场预期随着数字化业务的持续拓展,公司盈利能力将不断改善,从而吸引资金追捧。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.